Literature DB >> 16949995

Chapter 1: HPV in the etiology of human cancer.

Nubia Muñoz1, Xavier Castellsagué, Amy Berrington de González, Lutz Gissmann.   

Abstract

The causal role of human papillomavirus (HPV) in all cancers of the uterine cervix has been firmly established biologically and epidemiologically. Most cancers of the vagina and anus are likewise caused by HPV, as are a fraction of cancers of the vulva, penis, and oropharynx. HPV-16 and -18 account for about 70% of cancers of the cervix, vagina, and anus and for about 30-40% of cancers of the vulva, penis, and oropharynx. Other cancers causally linked to HPV are non-melanoma skin cancer and cancer of the conjunctiva. Although HPV is a necessary cause of cervical cancer, it is not a sufficient cause. Thus, other cofactors are necessary for progression from cervical HPV infection to cancer. Long-term use of hormonal contraceptives, high parity, tobacco smoking, and co-infection with HIV have been identified as established cofactors; co-infection with Chlamydia trachomatis (CT) and herpes simplex virus type-2 (HSV-2), immunosuppression, and certain dietary deficiencies are other probable cofactors. Genetic and immunological host factors and viral factors other than type, such as variants of type, viral load and viral integration, are likely to be important but have not been clearly identified.

Entities:  

Mesh:

Year:  2006        PMID: 16949995     DOI: 10.1016/j.vaccine.2006.05.115

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  366 in total

1.  Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer.

Authors:  Morgan A Marks; Philip E Castle; Mark Schiffman; Patti E Gravitt
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.

Authors:  Nadia Demarteau; Thomas Breuer; Baudouin Standaert
Journal:  Pharmacoeconomics       Date:  2012-04       Impact factor: 4.981

3.  Effects of a narrative HPV vaccination intervention aimed at reaching college women: a randomized controlled trial.

Authors:  Suellen Hopfer
Journal:  Prev Sci       Date:  2012-04

4.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

5.  Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.

Authors:  Chung-Hsiang Yuan; Maria Filippova; Sandy S Tungteakkhun; Penelope J Duerksen-Hughes; John L Krstenansky
Journal:  Bioorg Med Chem Lett       Date:  2012-01-10       Impact factor: 2.823

6.  A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Authors:  Hilary K Whitham; Stephen E Hawes; Haitao Chu; J Michael Oakes; Alan R Lifson; Nancy B Kiviat; Papa Salif Sow; Geoffrey S Gottlieb; Selly Ba; Marie P Sy; Shalini L Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-17       Impact factor: 4.254

7.  Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets.

Authors:  Yingfei Ma; Ramana Madupu; Ulas Karaoz; Carlos W Nossa; Liying Yang; Shibu Yooseph; Patrick S Yachimski; Eoin L Brodie; Karen E Nelson; Zhiheng Pei
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 8.  HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.

Authors:  Mary Roz Timbang; Michael W Sim; Arnaud F Bewley; D Gregory Farwell; Avinash Mantravadi; Michael G Moore
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

9.  Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.

Authors:  Jason Soh; Anne F Rositch; Laura Koutsky; Brandon L Guthrie; Robert Y Choi; Rose K Bosire; Ann Gatuguta; Jennifer S Smith; James Kiarie; Barbara Lohman-Payne; Carey Farquhar
Journal:  Int J STD AIDS       Date:  2013-09-18       Impact factor: 1.359

10.  A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars.

Authors:  Koen D Quint; Leen-Jan van Doorn; Bernhard Kleter; Maurits N C de Koning; Henk A M van den Munckhof; Servaas A Morre; Bram ter Harmsel; Elisabete Weiderpass; Gonneke Harbers; Willem J G Melchers; Wim G V Quint
Journal:  J Mol Diagn       Date:  2007-09-14       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.